Michael Gold to Humans
This is a "connection" page, showing publications Michael Gold has written about Humans.
Connection Strength
0.960
-
Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study. J Low Genit Tract Dis. 2019 Apr; 23(2):110-115.
Score: 0.037
-
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. J Low Genit Tract Dis. 2019 Apr; 23(2):87-101.
Score: 0.037
-
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. Radiology. 2017 05; 283(2):450-459.
Score: 0.032
-
High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. J Low Genit Tract Dis. 2013 Jan; 17(1):51-7.
Score: 0.024
-
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jun; 125(3):635-9.
Score: 0.023
-
A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer. Gynecol Oncol. 2012 May; 125(2):388-93.
Score: 0.023
-
Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment. J Low Genit Tract Dis. 2011 Jan; 15(1):11-4.
Score: 0.021
-
Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Gynecol Oncol. 2009 Feb; 112(2):337-41.
Score: 0.018
-
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer. Gynecol Oncol. 2008 Oct; 111(1):89-94.
Score: 0.018
-
Cervical dysplasia among women over 35 years of age. Am J Obstet Gynecol. 2008 Nov; 199(5):471.e1-5.
Score: 0.017
-
Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008 May 01; 112(9):1954-63.
Score: 0.017
-
PET in cervical cancer--implications for 'staging,' treatment planning, assessment of prognosis, and prediction of response. J Natl Compr Canc Netw. 2008 Jan; 6(1):37-45.
Score: 0.017
-
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol. 2007 Dec; 107(3):398-403.
Score: 0.017
-
Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am J Obstet Gynecol. 2007 Aug; 197(2):141.e1-6.
Score: 0.017
-
A LEEP cervical conization is rarely indicated for a two-step discrepancy. J Low Genit Tract Dis. 2007 Jul; 11(3):134-7.
Score: 0.016
-
Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007 Sep; 106(3):521-5.
Score: 0.016
-
A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007 Jun; 105(3):630-4.
Score: 0.016
-
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol. 2007 May; 105(2):299-303.
Score: 0.016
-
Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone. Gynecol Oncol. 2006 Feb; 100(2):379-84.
Score: 0.015
-
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol. 2005 Oct; 99(1):50-7.
Score: 0.015
-
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. Ann Oncol. 2024 Aug; 35(8):728-738.
Score: 0.013
-
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies. Gynecol Oncol. 2003 Aug; 90(2):325-30.
Score: 0.013
-
Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol. 2003 Apr; 26(2):171-3.
Score: 0.012
-
Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study. Gynecol Oncol. 2023 04; 171:67-75.
Score: 0.012
-
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. Gynecol Oncol. 2023 03; 170:11-18.
Score: 0.012
-
New options in contraception for adolescents. Curr Womens Health Rep. 2001 Oct; 1(2):116-23.
Score: 0.011
-
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). J Clin Oncol. 2021 06 10; 39(17):1842-1855.
Score: 0.011
-
Factors affecting fellowship satisfaction among gynecologic oncology fellows. Gynecol Oncol. 2001 Jan; 80(1):74-8.
Score: 0.010
-
Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
Score: 0.010
-
Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective. J Low Genit Tract Dis. 2020 Apr; 24(2):184-191.
Score: 0.010
-
Cadet basic training: an ethnographic study of stress and coping. Mil Med. 2000 Feb; 165(2):147-52.
Score: 0.010
-
Papillary adenocarcinoma of unknown primary in a young woman: a clinicopathologic correlation conference from the University of Oklahoma College of Medicine. J Okla State Med Assoc. 1999 Nov; 92(11):529-34.
Score: 0.010
-
Prescribing and managing oral contraceptive pills and emergency contraception for adolescents. Pediatr Clin North Am. 1999 Aug; 46(4):695-718.
Score: 0.009
-
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
Score: 0.009
-
Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstet Gynecol. 2018 09; 132(3):725-735.
Score: 0.009
-
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
Score: 0.009
-
Young women's attitudes toward injectable and implantable contraceptives. J Pediatr Adolesc Gynecol. 1998 Feb; 11(1):17-24.
Score: 0.009
-
Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol. 2017 12; 130(6):1218-1225.
Score: 0.008
-
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 04; 287(1):176-184.
Score: 0.008
-
Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. J Low Genit Tract Dis. 2017 Oct; 21(4):216-222.
Score: 0.008
-
ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. J Low Genit Tract Dis. 2017 Oct; 21(4):230-234.
Score: 0.008
-
Bilateral absence of the ovaries and distal fallopian tubes. A case report. J Reprod Med. 1997 Jun; 42(6):375-7.
Score: 0.008
-
A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results. J Low Genit Tract Dis. 2016 Apr; 20(2):119-25.
Score: 0.008
-
Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. J Low Genit Tract Dis. 2016 Apr; 20(2):154-61.
Score: 0.008
-
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Gynecol Oncol. 2016 05; 141(2):364-370.
Score: 0.007
-
Conversion reactions in adolescents. Pediatr Ann. 1995 Jun; 24(6):296-8, 301-2, 305-6.
Score: 0.007
-
Contraception update: implantable and injectable methods. Pediatr Ann. 1995 Apr; 24(4):203-7.
Score: 0.007
-
New progestin oral contraceptives and the female condom. Pediatr Ann. 1995 Apr; 24(4):211-6.
Score: 0.007
-
Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
Score: 0.007
-
Children of gay or lesbian parents. Pediatr Rev. 1994 Sep; 15(9):354-8; quiz 358.
Score: 0.007
-
Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol. 2014 Sep; 122(9):694-701.
Score: 0.007
-
Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
Score: 0.007
-
Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014 Jan; 33(1):64-73.
Score: 0.006
-
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan; 52(1):187-92.
Score: 0.006
-
Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol. 2013 Sep; 130(3):595-600.
Score: 0.006
-
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
Score: 0.006
-
A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013 May; 208(5):410.e1-6.
Score: 0.006
-
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr; 129(1):86-91.
Score: 0.006
-
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013 Feb; 128(2):155-9.
Score: 0.006
-
Reproducibility of linear array for human papillomavirus genotyping. J Clin Microbiol. 2013 Feb; 51(2):625-8.
Score: 0.006
-
The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
Score: 0.006
-
Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82.
Score: 0.006
-
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012 Nov 01; 30(31):3786-91.
Score: 0.006
-
Cotyledonoid dissecting leiomyoma of the uterus: a review of clinical, pathological, and radiological features. Int J Surg Pathol. 2012 Aug; 20(4):330-41.
Score: 0.006
-
Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
Score: 0.006
-
Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
Score: 0.006
-
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer. 2012 Sep 15; 131(6):E946-53.
Score: 0.006
-
Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol. 2012 May; 50(5):1564-70.
Score: 0.006
-
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012; 7(1):e29051.
Score: 0.006
-
Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology. 2010 Sep; 19(9):955-8.
Score: 0.005
-
Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol. 2010 Aug; 203(2):113.e1-6.
Score: 0.005
-
Distress in women with gynecologic cancer. Psychooncology. 2010 Jun; 19(6):665-8.
Score: 0.005
-
Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study. J Pediatr Adolesc Gynecol. 2010 Aug; 23(4):209-14.
Score: 0.005
-
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb; 29(2):95-101.
Score: 0.005
-
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. J Clin Oncol. 2010 Mar 01; 28(7):1215-23.
Score: 0.005
-
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
Score: 0.005
-
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol. 2009 Dec; 115(3):493-6.
Score: 0.005
-
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009 Aug; 114(2):365-9.
Score: 0.005
-
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.
Score: 0.005
-
Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol. 2009 Jun; 200(6):645.e1-5.
Score: 0.005
-
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer. 2009 Feb 15; 124(4):964-9.
Score: 0.005
-
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
Score: 0.005
-
Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. J Clin Microbiol. 2008 Aug; 46(8):2759-65.
Score: 0.004
-
A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Jul; 110(1):76-82.
Score: 0.004
-
Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes. Gynecol Oncol. 2008 Mar; 108(3):466-71.
Score: 0.004
-
Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Gynecol Oncol. 2008 Feb; 108(2):342-7.
Score: 0.004
-
Pathologic findings and outcomes for octogenarians presenting with uterine malignancy. Gynecol Oncol. 2007 Sep; 106(3):572-8.
Score: 0.004
-
Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. Gynecol Oncol. 2007 Sep; 106(3):498-501.
Score: 0.004
-
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer. 2007 Jul-Aug; 17(4):886-9.
Score: 0.004
-
Carcinosarcoma of the ovary-a case series. Gynecol Oncol. 2006 Jan; 100(1):128-32.
Score: 0.004
-
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol. 2005 Jun; 14(2):59-64.
Score: 0.004
-
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Gynecol Oncol. 2004 Oct; 95(1):70-6.
Score: 0.003
-
Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. Gynecol Oncol. 2004 Oct; 95(1):157-64.
Score: 0.003
-
Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol. 2004 Aug; 94(2):249-55.
Score: 0.003
-
Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study. Am J Obstet Gynecol. 2004 May; 190(5):1249-57.
Score: 0.003
-
ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2004 Feb; 103(2):317-26.
Score: 0.003
-
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003 Dec; 91(3):470-5.
Score: 0.003
-
Outpatient implantation of a central venous access system in gynecologic oncology patients. J Reprod Med. 2003 Nov; 48(11):875-81.
Score: 0.003
-
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol. 2003 May; 89(2):295-300.
Score: 0.003
-
Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol. 2003 Apr; 188(4):916-26.
Score: 0.003
-
Pitfalls of radiation survey after brachytherapy implant removal preceding Tl-201 study. Clin Nucl Med. 2002 Jul; 27(7):494-8.
Score: 0.003
-
Laparoscopic pelvic and paraaortic lymph node dissection in the obese. Gynecol Oncol. 2002 Mar; 84(3):426-30.
Score: 0.003
-
Panniculectomy with simultaneous gynecologic oncology surgery. Gynecol Oncol. 2001 Dec; 83(3):518-22.
Score: 0.003
-
Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol Oncol. 2001 Dec; 83(3):563-8.
Score: 0.003
-
Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol. 2001 Nov; 78(3):194-200; discussion 200-1.
Score: 0.003
-
Laparoscopic pelvic and paraaortic lymph node dissection: analysis of the first 100 cases. Gynecol Oncol. 2001 Sep; 82(3):498-503.
Score: 0.003
-
A retrospective analysis of radical hysterectomies done for cervical cancer: is there a role for the Pfannenstiel incision? Gynecol Oncol. 2001 Jun; 81(3):481-4.
Score: 0.003
-
Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma. J Natl Cancer Inst. 2001 Apr 04; 93(7):516-25.
Score: 0.003
-
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. J Med Chem. 1999 Oct 21; 42(21):4434-45.
Score: 0.002
-
Squamous metaplasia of the endometrium associated with HPV 6 and 11. Gynecol Oncol. 1997 Jul; 66(1):141-5.
Score: 0.002
-
CAUSES OF PATIENTS' DELAY IN DISEASES OF THE BREAST. Cancer. 1964 May; 17:564-77.
Score: 0.001